BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19461082)

  • 1. ASC/SIL Ratio for Cytotechnologists: A surrogate marker of screening sensitivity.
    Renshaw AA; DeschĂȘnes M; Auger M
    Am J Clin Pathol; 2009 Jun; 131(6):776-81. PubMed ID: 19461082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASC/SIL ratio for cytotechnologists: A survey of its utility in clinical practice.
    Renshaw AA; Auger M; Birdsong G; Cibas ES; Henry M; Hughes JH; Moriarty A; Tench W; Wilbur DC; Elsheikh TM
    Diagn Cytopathol; 2010 Mar; 38(3):180-3. PubMed ID: 19760762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
    Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
    Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
    [No Abstract]   [Full Text] [Related]  

  • 4. HPV detection rate in discordant Pap tests between cytotechnologists and pathologists.
    Chhieng DC; Bakdounes K; Connolly M; Gallaspy S; Roberson J; Eltoum I
    Diagn Cytopathol; 2009 May; 37(5):320-3. PubMed ID: 19191288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicability of the Bethesda System 2001 to a public health setting.
    Prandi S; Beccati D; De Aloysio G; Fulgenzi P; Gabrielli M; Ghirardini C; Rivasi F; Saragoni L; de Bianchi PS; Bucchi L
    Cancer; 2006 Oct; 108(5):271-6. PubMed ID: 16948127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Djemli A; Khetani K; Auger M
    Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the significance of workload on performance of cytotechnologists in gynecologic cytology: a study using rapid prescreening.
    Deschenes M; Renshaw AA; Auger M
    Cancer; 2008 Jun; 114(3):149-54. PubMed ID: 18412150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality control in cytopathology applied to screening for cervical carcinoma.
    Marsan C
    Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device.
    Wilgenbusch H; Mueller G; Neal M; Renshaw AA
    Diagn Cytopathol; 2011 Nov; 39(11):818-21. PubMed ID: 20949451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of cytotechnologists' parameters with their performance in rapid prescreening of papanicolaou smears.
    Djemli A; Khetani K; Case BW; Auger M
    Cancer; 2006 Oct; 108(5):306-10. PubMed ID: 16948125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality assurance in cervical smears: 100% rapid rescreening vs. 10% random rescreening.
    Amaral RG; Zeferino LC; Hardy E; Westin MC; Martinez EZ; Montemor EB
    Acta Cytol; 2005; 49(3):244-8. PubMed ID: 15966284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ASC/SIL ratio for cytopathologists as a quality control measure: a follow-up study.
    Nascimento AF; Cibas ES
    Am J Clin Pathol; 2007 Oct; 128(4):653-6. PubMed ID: 17875518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality control in Papanicolaou tests.
    Wachtel M
    Am J Clin Pathol; 2002 Nov; 118(5):804; author reply 805. PubMed ID: 12428803
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality assurance in cervical cytopathology.
    Light AM
    Cytopathology; 1997 Aug; 8(4):290-2. PubMed ID: 9252748
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality and liability issues with the Papanicolaou smear: the role of professional organizations in reform initiatives.
    Stanley MW
    Arch Pathol Lab Med; 1997 Mar; 121(3):321-6. PubMed ID: 9111127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Education and training for cytopathologists. Its role in quality assurance.
    Parker JE
    Acta Cytol; 1989; 33(4):448-50. PubMed ID: 2750433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State of the Art Symposium: prescreening and rescreening.
    O'Leary TJ
    Cancer; 2004 Dec; 102(6):331-3. PubMed ID: 15540232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytopathology in France.
    Cochand-Priollet B; Vincent S; Vielh P
    Cytopathology; 2004 Jun; 15(3):163-6. PubMed ID: 15165274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Becton Dickinson FocalPoint GS Imaging System: clinical trials demonstrate significantly improved sensitivity for the detection of important cervical lesions.
    Wilbur DC; Black-Schaffer WS; Luff RD; Abraham KP; Kemper C; Molina JT; Tench WD
    Am J Clin Pathol; 2009 Nov; 132(5):767-75. PubMed ID: 19846820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.